Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin-Reference-Cited by-同舟云学术

Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin

Published:2015-07 Issue:1-2 Volume:489 Page:277-284
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Cui Meng,Wu Wei,Hovgaard Lars,Lu Yi,Chen Dawei,Qi Jianping^ORCID

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. HPMC capsules: current status and future prospects;Al-Tabakha;J. Pharm. Pharm. Sci.,2010

2. Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications;Chattopadhyay;J. Liposome. Res.,2013

3. A comparison of the behavior of cholesterol, 7-dehydrocholesterol and ergosterol in phospholipid membranes;Chen;BBA Biomembranes,2012

4. Influence of the nature of the sterol on the behavior of palmitic acid/sterol mixtures and their derived liposomes;Cui;Biochim. Biophys. Acta, Biomembr.,2010

5. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation;Dai;Int. J. Nanomed.,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Borneol and lactoferrin dual-modified crocetin-loaded nanoliposomes enhance neuroprotection in HT22 cells and brain targeting in mice;European Journal of Medicinal Chemistry;2024-10

2. Cholesterol vs Ergosterol: Influence on the Dynamic and Structural Properties of the Cobalt-Based Metallosomal Bilayer Membrane;Molecular Pharmaceutics;2024-06-17

3. Glycyrrhizic Acid-Based Liposome for Tumor-Targeted Delivery of Cantharidin;ACS Applied Nano Materials;2024-01-02

4. Genetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions;World Journal of Diabetes;2023-12-15

5. Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins;Therapeutic Delivery;2023-12